What are the current economics?

Current investment amount, instrument, valuation, ownership, and follow-on are company-specific and not publicly standardized.

How large and long is the program?

More than a decade of science investing; no current accelerator cohort. Early-stage science venture investment with technical, commercial, corporate, strategic, and next-investor support.

Can founders participate remotely?

No universal remote or relocation policy.

What happens after the program?

Breakout describes long-term support and introductions to corporate partners and next-stage investors.

Breakout Ventures (Breakout Labs historical)

Current standard terms not publicly specified · US · Needs confirmation

Breakout Labs has evolved into Breakout Ventures, an early investor in science-driven companies. The current official site invites founders to talk but does not publish a cohort, deadline, standard check, ownership, or program duration.

Tier 3biodeep-techgrant

Official site Open in the live directory

Current application context

Program intake

Needs confirmation

This listing is historical and does not represent a current application cycle.

Checked Aug 21, 2026Authoritative source ↗

Key facts

Terms	Current standard terms not publicly specified
Stage	early science-driven company
Applications	Needs confirmation
Location	US
Remote friendly	No
Warm intro needed	No — open application
Sectors	bio, deep-tech, science
Status	closed

Always confirm on the official page before applying — dates and terms change.

Background

How the application really works

Use the current Breakout Ventures contact route as an investor conversation. Do not rely on old Breakout Labs application or grant terms.

Tips

Read the cited current official page before applying because program dates and terms are volatile.
State fit with the documented stage, geography, and attendance model; do not rely on an aggregator's old terms.
Ask for the complete investment, fee, and follow-on documents when the public page does not publish them.

Watch out for

Current investment amount, instrument, valuation, ownership, and follow-on are company-specific and not publicly standardized.
breakoutlabs.org redirects to Breakout Ventures. The old grant/accelerator terms are not a current standardized offer.

Track record

The current official portfolio includes Noetik, Epana Bio, ZymoChem, Twelve, Cytovale, Modern Meadow, and STRM.BIO.

No application volume or investment rate published.

Frequently asked questions

Is this program currently accepting applications?: Use the current Breakout Ventures contact route as an investor conversation. Do not rely on old Breakout Labs application or grant terms.
What are the current economics?: Current investment amount, instrument, valuation, ownership, and follow-on are company-specific and not publicly standardized.
How large and long is the program?: More than a decade of science investing; no current accelerator cohort. Early-stage science venture investment with technical, commercial, corporate, strategic, and next-investor support.
Can founders participate remotely?: No universal remote or relocation policy.
What happens after the program?: Breakout describes long-term support and introductions to corporate partners and next-stage investors.

Related accelerators

Founder InstituteWarrant or equity-pool terms vary by agreement · Global Berkeley SkyDeckApproximately 7.5% equity; confirm current fund terms · US Astranova (formerly Newchip)Program terms vary · Global a16z START (historical)Up to $1M (2022 launch terms; not confirmed current) · US (historical)Sequoia Open Source Fellowship0% equity grant support · Global NEA early programsCurrent standard terms not publicly specified · US

Sources

breakout.vc — Official current firm, investment thesis, portfolio, support model, and founder contact route (checked 2026-08-10)